WinHealth Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 43721682
Sandtoften 10, 2820 Gentofte
Income statement (kEUR)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | - 514.85 | - 104.43 |
EBIT | - 514.85 | - 104.43 |
Other financial expenses | -1.30 | -1.22 |
Pre-tax profit | - 516.16 | - 105.65 |
Net earnings | - 516.16 | - 105.65 |
Assets (kEUR)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Investments total | ||
Long term receivables total | ||
Inventories total | ||
Current other receivables | 27.46 | 4.24 |
Short term receivables total | 27.46 | 4.24 |
Cash and bank deposits | 6.60 | 47.43 |
Cash and cash equivalents | 6.60 | 47.43 |
Balance sheet total (assets) | 34.06 | 51.67 |
Equity and liabilities (kEUR)
2023 | 2024 | |
---|---|---|
Share capital | 5.38 | 5.38 |
Retained earnings | - 516.16 | |
Profit of the financial year | - 516.16 | - 105.65 |
Shareholders equity total | - 510.78 | - 616.43 |
Non-current owed to group member | 512.82 | 664.88 |
Non-current liabilities total | 512.82 | 664.88 |
Current trade creditors | 32.02 | 3.22 |
Current liabilities total | 32.02 | 3.22 |
Balance sheet total (liabilities) | 34.06 | 51.67 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.